+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Neuroscience Antibodies and Assays - Market Analysis, Trends, and Forecasts

  • ID: 4805278
  • Report
  • 183 pages
  • Global Industry Analysts, Inc
1 of 3

FEATURED COMPANIES

  • Abcam Plc
  • Biolegend
  • Bio-Rad Laboratories
  • Cell Signaling Technology
  • F. Hoffmann-La Roche Ag
  • Merck Kgaa
  • MORE
Neuroscience Antibodies and Assays market worldwide is projected to grow by US$2.4 Billion, driven by a compounded growth of 9.9%. Consumables, one of the segments analyzed and sized in this study, displays the potential to grow at over 10.3%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$3.6 Billion by the year 2025, Consumables will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 11.4% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$106.3 Million to the region's size and clout in the next 5 to 6 years. Over US$110.7 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Consumables will reach a market size of US$266.1 Million by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 9.4% over the next couple of years and add approximately US$404 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders.

Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include:
  • Abcam PLC
  • BioLegend, Inc.
  • Bio-Rad Laboratories, Inc.
  • Cell Signaling Technology, Inc.
  • F. Hoffmann-La Roche AG
  • GenScript Biotech Corporation
  • Merck KgaA
  • Rockland Immunochemicals, Inc.
  • Santa Cruz Biotechnology, Inc.
  • Siemens Healthineers
  • Tecan Group Ltd.
  • Thermo Fisher Scientific, Inc.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abcam Plc
  • Biolegend
  • Bio-Rad Laboratories
  • Cell Signaling Technology
  • F. Hoffmann-La Roche Ag
  • Merck Kgaa
  • MORE

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Global Competitor Market Shares

Neuroscience Antibodies and Assays Competitor Market Share Scenario Worldwide (in %): 2019 & 2025

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

TABLE 1: Neuroscience Antibodies and Assays Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025

TABLE 2: Neuroscience Antibodies and Assays Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017

TABLE 3: Neuroscience Antibodies and Assays Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025

TABLE 4: Consumables (Product) World Market by Region/Country in US$ Million: 2018 to 2025

TABLE 5: Consumables (Product) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017

TABLE 6: Consumables (Product) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025

TABLE 7: Instruments (Product) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025

TABLE 8: Instruments (Product) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017

TABLE 9: Instruments (Product) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025

TABLE 10: Pharmaceutical & Biotechnology Companies (End-Use) Global Opportunity Assessment in US$ Million by Region/Country: 2018-2025

TABLE 11: Pharmaceutical & Biotechnology Companies (End-Use) Historic Sales Analysis in US$ Million by Region/Country: 2009-2017

TABLE 12: Pharmaceutical & Biotechnology Companies (End-Use) Percentage Share Breakdown of Global Sales by Region/Country: 2009 VS 2019 VS 2025

TABLE 13: Academic & Research Institutes (End-Use) Worldwide Sales in US$ Million by Region/Country: 2018-2025

TABLE 14: Academic & Research Institutes (End-Use) Historic Demand Patterns in US$ Million by Region/Country: 2009-2017

TABLE 15: Academic & Research Institutes (End-Use) Market Share Shift across Key Geographies: 2009 VS 2019 VS 2025

TABLE 16: Hospitals & Diagnostic Centers (End-Use) Global Market Estimates & Forecasts in US$ Million by Region/Country: 2018-2025

TABLE 17: Hospitals & Diagnostic Centers (End-Use) Retrospective Demand Analysis in US$ Million by Region/Country: 2009-2017

TABLE 18: Hospitals & Diagnostic Centers (End-Use) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025

TABLE 19: Immunochemistry/Immunoassays (Technology) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025

TABLE 20: Immunochemistry/Immunoassays (Technology) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017

TABLE 21: Immunochemistry/Immunoassays (Technology) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

TABLE 22: Molecular Diagnostics (Technology) World Market Estimates and Forecasts by Region/Country in US$ Million: 2018 to 2025

TABLE 23: Molecular Diagnostics (Technology) Market Historic Review by Region/Country in US$ Million: 2009 to 2017

TABLE 24: Molecular Diagnostics (Technology) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025

TABLE 25: Clinical Chemistry (Technology) World Market by Region/Country in US$ Million: 2018 to 2025

TABLE 26: Clinical Chemistry (Technology) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017

TABLE 27: Clinical Chemistry (Technology) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

TABLE 28: Other Technologies (Technology) World Market Estimates and Forecasts in US$ Million by Region/Country: 2018 to 2025

TABLE 29: Other Technologies (Technology) Market Worldwide Historic Review by Region/Country in US$ Million: 2009 to 2017

TABLE 30: Other Technologies (Technology) Market Percentage Share Distribution by Region/Country: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES

Market Facts & Figures

US Neuroscience Antibodies and Assays Market Share (in %) by Company: 2019 & 2025

TABLE 31: United States Neuroscience Antibodies and Assays Market Estimates and Projections in US$ Million by Product: 2018 to 2025

TABLE 32: Neuroscience Antibodies and Assays Market in the United States by Product: A Historic Review in US$ Million for 2009-2017

TABLE 33: United States Neuroscience Antibodies and Assays Market Share Breakdown by Product: 2009 VS 2019 VS 2025

TABLE 34: United States Neuroscience Antibodies and Assays Latent Demand Forecasts in US$ Million by End-Use: 2018 to 2025

TABLE 35: Neuroscience Antibodies and Assays Historic Demand Patterns in the United States by End-Use in US$ Million for 2009-2017

TABLE 36: Neuroscience Antibodies and Assays Market Share Breakdown in the United States by End-Use: 2009 VS 2019 VS 2025

TABLE 37: Neuroscience Antibodies and Assays Market in US$ Million in the United States by Technology: 2018-2025

TABLE 38: United States Neuroscience Antibodies and Assays Market Retrospective Analysis in US$ Million by Technology: 2009-2017

TABLE 39: United States Neuroscience Antibodies and Assays Market Share Breakdown by Technology: 2009 VS 2019 VS 2025

CANADA

TABLE 40: Canadian Neuroscience Antibodies and Assays Market Estimates and Forecasts in US$ Million by Product: 2018 to 2025

TABLE 41: Canadian Neuroscience Antibodies and Assays Historic Market Review by Product in US$ Million: 2009-2017

TABLE 42: Neuroscience Antibodies and Assays Market in Canada: Percentage Share Breakdown of Sales by Product for 2009, 2019, and 2025

TABLE 43: Canadian Neuroscience Antibodies and Assays Market Quantitative Demand Analysis in US$ Million by End-Use: 2018 to 2025

TABLE 44: Neuroscience Antibodies and Assays Market in Canada: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2009-2017

TABLE 45: Canadian Neuroscience Antibodies and Assays Market Share Analysis by End-Use: 2009 VS 2019 VS 2025

TABLE 46: Neuroscience Antibodies and Assays Market Analysis in Canada in US$ Million by Technology: 2018-2025

TABLE 47: Neuroscience Antibodies and Assays Market in Canada: Historic Review in US$ Million by Technology for the Period 2009-2017

TABLE 48: Canadian Neuroscience Antibodies and Assays Market Share Breakdown by Technology: 2009 VS 2019 VS 2025

JAPAN

TABLE 49: Japanese Market for Neuroscience Antibodies and Assays: Annual Sales Estimates and Projections in US$ Million by Product for the Period 2018-2025

TABLE 50: Neuroscience Antibodies and Assays Market in Japan: Historic Sales Analysis in US$ Million by Product for the Period 2009-2017

TABLE 51: Japanese Neuroscience Antibodies and Assays Market Share Analysis by Product: 2009 VS 2019 VS 2025

TABLE 52: Japanese Demand Estimates and Forecasts for Neuroscience Antibodies and Assays in US$ Million by End-Use: 2018 to 2025

TABLE 53: Japanese Neuroscience Antibodies and Assays Market in US$ Million by End-Use: 2009-2017

TABLE 54: Neuroscience Antibodies and Assays Market Share Shift in Japan by End-Use: 2009 VS 2019 VS 2025

TABLE 55: Japanese Medium & Long-Term Outlook for Neuroscience Antibodies and Assays Market in US$ Million by Technology: 2018-2025

TABLE 56: Neuroscience Antibodies and Assays Market in Japan in US$ Million by Technology: 2009-2017

TABLE 57: Japanese Neuroscience Antibodies and Assays Market Percentage Share Distribution by Technology: 2009 VS 2019 VS 2025

CHINA

TABLE 58: Chinese Neuroscience Antibodies and Assays Market Growth Prospects in US$ Million by Product for the Period 2018-2025

TABLE 59: Neuroscience Antibodies and Assays Historic Market Analysis in China in US$ Million by Product: 2009-2017

TABLE 60: Chinese Neuroscience Antibodies and Assays Market by Product: Percentage Breakdown of Sales for 2009, 2019, and 2025

TABLE 61: Chinese Demand for Neuroscience Antibodies and Assays in US$ Million by End-Use: 2018 to 2025

TABLE 62: Neuroscience Antibodies and Assays Market Review in China in US$ Million by End-Use: 2009-2017

TABLE 63: Chinese Neuroscience Antibodies and Assays Market Share Breakdown by End-Use: 2009 VS 2019 VS 2025

TABLE 64: Neuroscience Antibodies and Assays Market Estimates and Forecasts in China in US$ Million by Technology: 2018-2025

TABLE 65: Chinese Neuroscience Antibodies and Assays Retrospective Market Scenario in US$ Million by Technology: 2009-2017

TABLE 66: Neuroscience Antibodies and Assays Market in China: Percentage Share Analysis by Technology for 2009, 2019, and 2025

EUROPE

Market Facts & Figures

European Neuroscience Antibodies and Assays Market: Competitor Market Share Scenario (in %) for 2019 & 2025

TABLE 67: European Neuroscience Antibodies and Assays Market Demand Scenario in US$ Million by Region/Country: 2018-2025

TABLE 68: Neuroscience Antibodies and Assays Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017

TABLE 69: European Neuroscience Antibodies and Assays Market Share Shift by Region/Country: 2009 VS 2019 VS 2025

TABLE 70: European Neuroscience Antibodies and Assays Market Estimates and Forecasts in US$ Million by Product: 2018-2025

TABLE 71: Neuroscience Antibodies and Assays Market in Europe in US$ Million by Product: A Historic Review for the Period 2009-2017

TABLE 72: European Neuroscience Antibodies and Assays Market Share Breakdown by Product: 2009 VS 2019 VS 2025

TABLE 73: European Neuroscience Antibodies and Assays Addressable Market Opportunity in US$ Million by End-Use: 2018-2025

TABLE 74: Neuroscience Antibodies and Assays Market in Europe: Summarization of Historic Demand in US$ Million by End-Use for the Period 2009-2017

TABLE 75: European Neuroscience Antibodies and Assays Market Share Analysis by End-Use: 2009 VS 2019 VS 2025

TABLE 76: European Neuroscience Antibodies and Assays Market Assessment in US$ Million by Technology: 2018-2025

TABLE 77: European Neuroscience Antibodies and Assays Historic Market Review in US$ Million by Technology: 2009-2017

TABLE 78: Neuroscience Antibodies and Assays Market in Europe: Percentage Breakdown of Sales by Technology for 2009, 2019, and 2025

FRANCE

TABLE 79: Neuroscience Antibodies and Assays Market in France by Product: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 80: French Neuroscience Antibodies and Assays Historic Market Scenario in US$ Million by Product: 2009-2017

TABLE 81: French Neuroscience Antibodies and Assays Market Share Analysis by Product: 2009 VS 2019 VS 2025

TABLE 82: Neuroscience Antibodies and Assays Quantitative Demand Analysis in France in US$ Million by End-Use: 2018-2025

TABLE 83: French Neuroscience Antibodies and Assays Historic Market Review in US$ Million by End-Use: 2009-2017

TABLE 84: French Neuroscience Antibodies and Assays Market Share Analysis: A 17-Year Perspective by End-Use for 2009, 2019, and 2025

TABLE 85: French Neuroscience Antibodies and Assays Market Estimates and Projections in US$ Million by Technology: 2018-2025

TABLE 86: French Neuroscience Antibodies and Assays Historic Market Analysis in US$ Million by Technology: 2009-2017

TABLE 87: French Neuroscience Antibodies and Assays Market Share Breakdown by Technology: 2009 VS 2019 VS 2025

GERMANY

TABLE 88: Neuroscience Antibodies and Assays Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Product for the Period 2018-2025

TABLE 89: German Neuroscience Antibodies and Assays Historic Market Analysis in US$ Million by Product: 2009-2017

TABLE 90: German Neuroscience Antibodies and Assays Market Share Breakdown by Product: 2009 VS 2019 VS 2025

TABLE 91: Neuroscience Antibodies and Assays Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by End-Use for the Period 2018-2025

TABLE 92: German Neuroscience Antibodies and Assays Market in Retrospect in US$ Million by End-Use: 2009-2017

TABLE 93: Neuroscience Antibodies and Assays Market Share Distribution in Germany by End-Use: 2009 VS 2019 VS 2025

TABLE 94: German Neuroscience Antibodies and Assays Latent Demand Forecasts in US$ Million by Technology: 2018-2025

TABLE 95: Neuroscience Antibodies and Assays Market in Germany: A Historic Perspective by Technology in US$ Million for the Period 2009-2017

TABLE 96: German Neuroscience Antibodies and Assays Market Share Breakdown by Technology: 2009 VS 2019 VS 2025

ITALY

TABLE 97: Italian Neuroscience Antibodies and Assays Market Growth Prospects in US$ Million by Product for the Period 2018-2025

TABLE 98: Neuroscience Antibodies and Assays Historic Market Analysis in Italy in US$ Million by Product: 2009-2017

TABLE 99: Italian Neuroscience Antibodies and Assays Market by Product: Percentage Breakdown of Sales for 2009, 2019, and 2025

TABLE 100: Italian Demand for Neuroscience Antibodies and Assays in US$ Million by End-Use: 2018 to 2025

TABLE 101: Neuroscience Antibodies and Assays Market Review in Italy in US$ Million by End-Use: 2009-2017

TABLE 102: Italian Neuroscience Antibodies and Assays Market Share Breakdown by End-Use: 2009 VS 2019 VS 2025

TABLE 103: Neuroscience Antibodies and Assays Market Estimates and Forecasts in Italy in US$ Million by Technology: 2018-2025

TABLE 104: Italian Neuroscience Antibodies and Assays Retrospective Market Scenario in US$ Million by Technology: 2009-2017

TABLE 105: Neuroscience Antibodies and Assays Market in Italy: Percentage Share Analysis by Technology for 2009, 2019, and 2025

UNITED KINGDOM

TABLE 106: United Kingdom Market for Neuroscience Antibodies and Assays: Annual Sales Estimates and Projections in US$ Million by Product for the Period 2018-2025

TABLE 107: Neuroscience Antibodies and Assays Market in the United Kingdom: Historic Sales Analysis in US$ Million by Product for the Period 2009-2017

TABLE 108: United Kingdom Neuroscience Antibodies and Assays Market Share Analysis by Product: 2009 VS 2019 VS 2025

TABLE 109: United Kingdom Demand Estimates and Forecasts for Neuroscience Antibodies and Assays in US$ Million by End-Use: 2018 to 2025

TABLE 110: United Kingdom Neuroscience Antibodies and Assays Market in US$ Million by End-Use: 2009-2017

TABLE 111: Neuroscience Antibodies and Assays Market Share Shift in the United Kingdom by End-Use: 2009 VS 2019 VS 2025

TABLE 112: United Kingdom Medium & Long-Term Outlook for Neuroscience Antibodies and Assays Market in US$ Million by Technology: 2018-2025

TABLE 113: Neuroscience Antibodies and Assays Market in the United Kingdom in US$ Million by Technology: 2009-2017

TABLE 114: United Kingdom Neuroscience Antibodies and Assays Market Percentage Share Distribution by Technology: 2009 VS 2019 VS 2025

REST OF EUROPE

TABLE 115: Rest of Europe Neuroscience Antibodies and Assays Market Estimates and Forecasts in US$ Million by Product: 2018-2025

TABLE 116: Neuroscience Antibodies and Assays Market in Rest of Europe in US$ Million by Product: A Historic Review for the Period 2009-2017

TABLE 117: Rest of Europe Neuroscience Antibodies and Assays Market Share Breakdown by Product: 2009 VS 2019 VS 2025

TABLE 118: Rest of Europe Neuroscience Antibodies and Assays Addressable Market Opportunity in US$ Million by End-Use: 2018-2025

TABLE 119: Neuroscience Antibodies and Assays Market in Rest of Europe: Summarization of Historic Demand in US$ Million by End-Use for the Period 2009-2017

TABLE 120: Rest of Europe Neuroscience Antibodies and Assays Market Share Analysis by End-Use: 2009 VS 2019 VS 2025

TABLE 121: Rest of Europe Neuroscience Antibodies and Assays Market Assessment in US$ Million by Technology: 2018-2025

TABLE 122: Rest of Europe Neuroscience Antibodies and Assays Historic Market Review in US$ Million by Technology: 2009-2017

TABLE 123: Neuroscience Antibodies and Assays Market in Rest of Europe: Percentage Breakdown of Sales by Technology for 2009, 2019, and 2025

ASIA-PACIFIC

TABLE 124: Neuroscience Antibodies and Assays Market in Asia-Pacific by Product: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 125: Asia-Pacific Neuroscience Antibodies and Assays Historic Market Scenario in US$ Million by Product: 2009-2017

TABLE 126: Asia-Pacific Neuroscience Antibodies and Assays Market Share Analysis by Product: 2009 VS 2019 VS 2025

TABLE 127: Neuroscience Antibodies and Assays Quantitative Demand Analysis in Asia-Pacific in US$ Million by End-Use: 2018-2025

TABLE 128: Asia-Pacific Neuroscience Antibodies and Assays Historic Market Review in US$ Million by End-Use: 2009-2017

TABLE 129: Asia-Pacific Neuroscience Antibodies and Assays Market Share Analysis: A 17-Year Perspective by End-Use for 2009, 2019, and 2025

TABLE 130: Asia-Pacific Neuroscience Antibodies and Assays Market Estimates and Projections in US$ Million by Technology: 2018-2025

TABLE 131: Asia-Pacific Neuroscience Antibodies and Assays Historic Market Analysis in US$ Million by Technology: 2009-2017

TABLE 132: Asia-Pacific Neuroscience Antibodies and Assays Market Share Breakdown by Technology: 2009 VS 2019 VS 2025

REST OF WORLD

TABLE 133: Rest of World Neuroscience Antibodies and Assays Market Estimates and Forecasts in US$ Million by Product: 2018 to 2025

TABLE 134: Rest of World Neuroscience Antibodies and Assays Historic Market Review by Product in US$ Million: 2009-2017

TABLE 135: Neuroscience Antibodies and Assays Market in Rest of World: Percentage Share Breakdown of Sales by Product for 2009, 2019, and 2025

TABLE 136: Rest of World Neuroscience Antibodies and Assays Market Quantitative Demand Analysis in US$ Million by End-Use: 2018 to 2025

TABLE 137: Neuroscience Antibodies and Assays Market in Rest of World: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2009-2017

TABLE 138: Rest of World Neuroscience Antibodies and Assays Market Share Analysis by End-Use: 2009 VS 2019 VS 2025

TABLE 139: Neuroscience Antibodies and Assays Market Analysis in Rest of World in US$ Million by Technology: 2018-2025

TABLE 140: Neuroscience Antibodies and Assays Market in Rest of World: Historic Review in US$ Million by Technology for the Period 2009-2017

TABLE 141: Rest of World Neuroscience Antibodies and Assays Market Share Breakdown by Technology: 2009 VS 2019 VS 2025

IV. COMPETITION

ABCAM PLC

BIO-RAD LABORATORIES

BIOLEGEND

CELL SIGNALING TECHNOLOGY

F. HOFFMANN-LA ROCHE AG

GENSCRIPT BIOTECH CORPORATION

MERCK KGAA

ROCKLAND IMMUNOCHEMICALS

SANTA CRUZ BIOTECHNOLOGY

SIEMENS HEALTHINEERS

TECAN GROUP

THERMO FISHER SCIENTIFIC

V. CURATED RESEARCH

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Abcam Plc
  • Bio-Rad Laboratories
  • Biolegend
  • Cell Signaling Technology
  • F. Hoffmann-La Roche Ag
  • Genscript Biotech Corporation
  • Merck Kgaa
  • Rockland Immunochemicals
  • Santa Cruz Biotechnology
  • Siemens Healthineers
  • Tecan Group
  • Thermo Fisher Scientific
Note: Product cover images may vary from those shown
Adroll
adroll